About 203 results

ALLMedicine™ Cutaneous B-cell Lymphoma Center

Research & Reviews  69 results

Analysis of clonality in cutaneous B-cell lymphoma and B-cell pseudolymphoma using skin...
The Journal of Dermatology; Nakagawa Y, Hamada T et. al.

Jul 16th, 2021 - To identify clonal neoplastic cells in skin affected by B-cell lymphoma using skin flow cytometry (FCM) techniques, we investigated light-chain restriction using skin FCM with clonality assessed by polymerase chain reaction and light-chain restric...

Prominent Blasts in Primary Cutaneous CD4+ Small/Medium T-Cell Lymphoproliferative Diso...
The American Journal of Dermatopathology; Bakr F, Wain EM et. al.

May 15th, 2021 - Primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder (PCSM-LPD), recently downgraded from a T-cell lymphoma, is a poorly characterized histopathological entity. Presenting as a solitary lesion that often grows rapidly, it may ra...

Metastasis of Cutaneous B-Cell Lymphoma Affecting the Metatarsal Head: A Case Report.
Journal of the American Podiatric Medical Association; Huchital M, Hoda ST et. al.

Apr 20th, 2021 - There are few reported cases of non-Hodgkin's lymphoma metastasis to bone in the lower extremities. The authors present a case of cutaneous B-cell lymphoma thought to be in remission, with metastasis to the first metatarsal head with involvement i...

Primary cutaneous follicle center lymphoma with extensive plasmacytic differentiation a...
Journal of Cutaneous Pathology; Kelley JT, Brown NA et. al.

Apr 1st, 2021 - Primary cutaneous follicle center lymphoma (PCFCL) is the most common cutaneous B-cell lymphoma. The typical immunophenotype includes expression of both CD20 and BCL6, with the majority of cases lacking expression of CD10, BCL2, and the characteri...

Oncolytic Virotherapy Shows Promise for Cutaneous B-cell Lymphoma.
Cancer Discovery;

Jan 31st, 2021 - T-VEC virotherapy yielded complete responses in injected lesions in 46% of patients in a phase I trial.

see more →

Clinicaltrials.gov  1 results

Study to Evaluate the Safety and Efficacy of Adeno-IFN Gamma in Cutaneous B-cell Lymphoma

Jul 16th, 2014 - The primary objective of this study is to evaluate the efficacy of a four-month dosing period of intra-lesional injection of TG1042 in patients with relapsing CBCL. Patients will receive intra-tumoral injections of an adenoviral vector construct c...

see more →

News  9 results

Grouped Erythematous Papules and Plaques on the Trunk
Dean David George, MD, Nour Almardini, MD et. al.

Jul 8th, 2019 - The Diagnosis: Cutaneous B-Cell Lymphoma, Follicle Center Subtype A 4-mm punch biopsy through the center of the largest lesion on the right posterior shoulder demonstrated a superficial and deep dermal atypical lymphoid infiltrate composed predomi.

Cutavirus shows no association with primary cutaneous lymphoma
Heidi Splete

Jun 27th, 2018 - The parvovirus known as cutavirus appears unlikely to play a pathogenic role in primary cutaneous B- and T-cell lymphoma, based on data from 189 biopsies. Although researchers have long suspected viruses of a role in primary cutaneous lymphomas, “.

Background color a dermoscopic clue to cutaneous B-cell lymphoma
Bianca Nogrady

Jan 30th, 2018 - A salmon-colored background and prominent serpentine blood vessels are two characteristic features of primary cutaneous B-cell lymphoma (PCBCL) that can be identified dermoscopically and may aid diagnosis, researchers say. In the January issue of.

Rare epidermotropic MZL yields to rituximab
Neil Osterweil

Nov 27th, 2017 - Epidermotropic marginal zone lymphoma (MZL), a rare cutaneous B-cell lymphoma identified in only eight patients to date, appears to be responsive to rituximab, according to authors of a case report. A 69-year-old man who presented with a generaliz.

Erythematous Pearly Papule on the Chest
Nikoleta Brankov, MD, Amandeep Sandhu, MD et. al.

Mar 6th, 2017 - Primary Cutaneous B-cell Lymphoma Cutaneous B-cell lymphomas (CBCLs) are a diverse but rare group of cutaneous lympho­proliferative neoplasms that make up approximately 20% of the total number of hematolymphoid neoplasms primary to the skin. 1 Thes.

see more →

Patient Education  2 results see all →